GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panion & Bf Biotech Inc (TPE:1760) » Definitions » Cyclically Adjusted FCF per Share

Panion & Bf Biotech (TPE:1760) Cyclically Adjusted FCF per Share : NT$0.97 (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Panion & Bf Biotech Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Panion & Bf Biotech's adjusted free cash flow per share for the three months ended in Mar. 2024 was NT$-0.109. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is NT$0.97 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Panion & Bf Biotech's average Cyclically Adjusted FCF Growth Rate was 2.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2024-06-10), Panion & Bf Biotech's current stock price is NT$97.70. Panion & Bf Biotech's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was NT$0.97. Panion & Bf Biotech's Cyclically Adjusted Price-to-FCF of today is 100.72.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Panion & Bf Biotech was 187.89. The lowest was 96.91. And the median was 131.88.


Panion & Bf Biotech Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Panion & Bf Biotech's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panion & Bf Biotech Cyclically Adjusted FCF per Share Chart

Panion & Bf Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 1.14 1.00

Panion & Bf Biotech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.95 0.97 0.82 1.00 0.97

Competitive Comparison of Panion & Bf Biotech's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Panion & Bf Biotech's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Panion & Bf Biotech's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Panion & Bf Biotech's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Panion & Bf Biotech's Cyclically Adjusted Price-to-FCF falls into.



Panion & Bf Biotech Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Panion & Bf Biotech's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.109/131.7762*131.7762
=-0.109

Current CPI (Mar. 2024) = 131.7762.

Panion & Bf Biotech Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201206 0.000 96.819 0.000
201212 0.000 96.871 0.000
201306 0.000 98.518 0.000
201312 0.000 98.326 0.000
201406 0.000 100.560 0.000
201412 0.000 99.070 0.000
201506 0.000 100.684 0.000
201512 0.000 99.792 0.000
201606 0.000 101.688 0.000
201609 0.000 101.861 0.000
201612 0.000 101.863 0.000
201703 0.347 102.862 0.445
201706 0.509 103.349 0.649
201709 0.102 104.136 0.129
201712 0.322 104.011 0.408
201803 0.329 105.290 0.412
201806 -0.006 106.317 -0.007
201809 -0.328 106.507 -0.406
201812 0.516 105.998 0.641
201903 0.186 107.251 0.229
201906 -1.038 108.070 -1.266
201909 -0.481 108.329 -0.585
201912 1.071 108.420 1.302
202003 -0.460 108.902 -0.557
202006 0.115 108.767 0.139
202009 -0.236 109.815 -0.283
202012 -0.880 109.897 -1.055
202103 0.204 111.754 0.241
202106 1.747 114.631 2.008
202109 0.736 115.734 0.838
202112 0.282 117.630 0.316
202203 0.107 121.301 0.116
202206 1.854 125.017 1.954
202209 0.801 125.227 0.843
202212 0.635 125.222 0.668
202303 -1.017 127.348 -1.052
202306 0.316 128.729 0.323
202309 -0.833 129.860 -0.845
202312 1.482 129.419 1.509
202403 -0.109 131.776 -0.109

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Panion & Bf Biotech  (TPE:1760) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Panion & Bf Biotech's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=97.70/0.97
=100.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Panion & Bf Biotech was 187.89. The lowest was 96.91. And the median was 131.88.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Panion & Bf Biotech Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Panion & Bf Biotech's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Panion & Bf Biotech (TPE:1760) Business Description

Industry
Traded in Other Exchanges
N/A
Address
No. 3, Park Street, 16th Floor, F Building, Nangang District, Taipei, TWN, 11503
Panion & Bf Biotech Inc operates as a biotech and pharmaceutical company. It is engaged in research and development of pharmaceuticals and new drugs. It focuses on pharmaceuticals, cosmeceuticals, nutraceuticals, and medical devices sectors. It has four core business groups such as disease treatment, disease prevention, disease diagnosis, and delayed aging. It has two geographic segments Taiwan segment and China, Hong Kong, and Macau segment. It generate majority of the revenue from Taiwan segment.

Panion & Bf Biotech (TPE:1760) Headlines

No Headlines